Algert Global’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-130,627
| Closed | -$2.06M | – | 1606 |
|
|
2024
Q1 | $2.06M | Sell |
130,627
-141,044
| -52% | -$2.22M | 0.08% | 406 |
|
|
2023
Q4 | $4.38M | Buy |
271,671
+178,261
| +191% | +$2.88M | 0.18% | 178 |
|
|
2023
Q3 | $1.19M | Buy |
+93,410
| New | +$1.19M | 0.06% | 527 |
|
|
2023
Q2 | – | Sell |
-15,492
| Closed | -$239K | – | 1313 |
|
|
2023
Q1 | $239K | Buy |
15,492
+1,416
| +10% | +$21.8K | 0.01% | 992 |
|
|
2022
Q4 | $231K | Sell |
14,076
-18,530
| -57% | -$304K | 0.01% | 987 |
|
|
2022
Q3 | $603K | Buy |
32,606
+15
| +0% | +$277 | 0.04% | 744 |
|
|
2022
Q2 | $429K | Buy |
32,591
+15,010
| +85% | +$198K | 0.03% | 808 |
|
|
2022
Q1 | $163K | Buy |
17,581
+6,378
| +57% | +$59.1K | 0.01% | 1067 |
|
|
2021
Q4 | $109K | Hold |
11,203
| – | – | 0.01% | 910 |
|
|
2021
Q3 | $381K | Buy |
+11,203
| New | +$381K | 0.05% | 658 |
|
|
2021
Q1 | – | Sell |
-4,245
| Closed | -$242K | – | 555 |
|
|
2020
Q4 | $242K | Hold |
4,245
| – | – | 0.07% | 326 |
|
|
2020
Q3 | $218K | Sell |
4,245
-2,448
| -37% | -$126K | 0.07% | 305 |
|
|
2020
Q2 | $400K | Sell |
6,693
-1,263
| -16% | -$75.5K | 0.14% | 225 |
|
|
2020
Q1 | $328K | Buy |
+7,956
| New | +$328K | 0.14% | 234 |
|
|
2019
Q4 | – | Sell |
-9,965
| Closed | -$338K | – | 449 |
|
|
2019
Q3 | $338K | Buy |
+9,965
| New | +$338K | 0.13% | 200 |
|